Keweenaw Report Your Source for Local News and Sports
Aspirus is among the first in the country to implement a new heart stent technology that promotes faster healing and promises fewer complications.
Doctors are now treating patients at Aspirus Heart & Vascular at Aspirus Wausau Hospital with a newly approved SYNERGY Coronary Stent, a highly anticipated new technology to treat heart disease.
Manufactured by Boston Scientific and approved by the Food and Drug Administration in October, the SYNERGY stent has been in development for more than 10 years and studied in more than 15,000 patients worldwide.
Aspirus Wausau Hospital is directly integrated to Aspirus Keweenaw Hospital…who now have a cardiologist on site, providing care for patients at Aspirus Keweenaw Laurium Clinic and Aspirus Houghton Clinic.
Here is the full press release from Aspirus:
WAUSAU, Wis. – Doctors are now treating patients at Aspirus Heart & Vascular with a newly approved SYNERGY™ Coronary Stent, making them among the first patients in the nation to benefit from this highly anticipated new technology to treat heart disease.
“The SYNERGY stent is a leading-edge treatment we are able to deliver to our patients,” said Timothy Grady, DO, FACC, cardiologist with Aspirus Heart & Vascular. “This next generation heart stent promotes faster healing, may decrease medication use and helps lower the risk of complications.”
Stents are tiny mesh tubes doctors use to prop open clogged arteries, allowing blood to flow freely to the heart. The SYNERGY Stent has a bioabsorbable polymer that breaks down and is fully absorbed after the drug is released. Faster healing is supported by eliminating permanent polymer exposure, which has been associated with complications such as blood clots and recurrence of vessel narrowing.
Manufactured by Boston Scientific and approved by the Food and Drug Administration in October, the SYNERGY stent has been in development for more than 10 years and studied in more than 15,000 patients worldwide. To download images and video showing the SYNERGY stents unique properties, please click here.
Aspirus Heart & Vascular continues to be a leader in heart care and research, providing state-of-the-art cardiovascular services for patients in north central Wisconsin and the Upper Peninsula of Michigan. It is consistently ranked by national quality benchmarking organizations as a leader in clinical quality and patient safety. The SYNERGY stent treatment is the latest in a long line of pioneering services and procedures offered by Aspirus.
About Aspirus Heart & Vascular
Aspirus Heart & Vascular is a group of award-winning doctors dedicated to providing the highest quality comprehensive care throughout Wisconsin and Michigan. Aspirus is known for its solid record of innovation, outstanding outcomes, advanced treatments, and exceptional patient care. For more information, visit www.aspirus.org/heart.
About Aspirus Health System
Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. With more than 7,000 employees, Aspirus serves communities throughout northern and central Wisconsin, as well as the western Upper Peninsula of Michigan. The integrated system includes four hospitals in Michigan and four hospitals in Wisconsin, 50 clinics, home health and hospice care, pharmacies, critical care and helicopter transport, medical goods, nursing homes and high-quality affiliated physicians. For more information, visit www.aspirus.org.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com.
